Physician profile
Danna Raslan
NPI 1407417132
$3,021.73
in general payments reported to CMS, 2019-2025
19 companies · $1,170 in 2025
The $1,170 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.76 · 2022: $252 · 2023: $335 · 2024: $1,246 · 2025: $1,170.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,856 · Travel and Lodging: $895.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,856.25 |
| Travel and Lodging | $894.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $986.21 | 2024 | |
| Sumitomo Pharma America, INC. | $711.46 | 2023-2025 | Gemtesa, Orgovyx |
| Boston Scientific Corporation | $455.00 | 2019-2025 | Bulkamid, Rezum Generator, Lithoclast |
| Janssen Biotech, INC. | $203.50 | 2024-2025 | Erleada |
| Endo USA, INC. | $128.75 | 2024-2025 | Xiaflex, Aveed |
| Bayer Healthcare Pharmaceuticals INC. | $122.53 | 2023 | |
| Astellas Pharma US INC | $88.61 | 2025 | Xtandi |
| Progenics Pharmaceuticals, INC. | $49.54 | 2025 | |
| Teleflex LLC | $35.84 | 2023-2025 | Urolift, Barrigel |
| Photocure INC | $32.26 | 2025 | Cysview |
| Verity Pharmaceuticals INC. | $30.91 | 2025 | Trelstar |
| Srs Medical Systems, INC. | $28.65 | 2024-2025 | Urocuff-Dc Disposable, Single, Ct3000 Pro Base Unit |
| Abbvie INC. | $26.90 | 2025 | |
| Lantheus Medical Imaging, INC. | $24.43 | 2024 | |
| Axonics, INC. | $22.34 | 2024 | Bulkamid, Axonics |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Immunitybio, INC. | $21.58 | 2025 | |
| Sun Pharmaceutical Industries INC. | $19.10 | 2024 | |
| Ferring Pharmaceuticals INC. | $18.20 | 2025 | Adstiladrin |
| Merck Sharp & Dohme LLC | $15.92 | 2025 | Keytruda |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danna Raslan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.